Related Experiment Video
Updated: Sep 1, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Post-COVID-19 outcomes of non-dialysis dependent chronic kidney disease patients: a national, multicenter, controlled
Serhat Karadag1, Savas Ozturk2, Mustafa Arici3
1Department of Nephrology, University of Health Sciences, Haseki Training and Research Hospital, Istanbul, Turkey.
Insights
Patients with chronic kidney disease (CKD) who survived COVID-19 experienced higher mortality and worsening kidney function post-infection. This study highlights the significant long-term risks of COVID-19 for CKD patients not on dialysis.
Area of Science:
- Nephrology
- Infectious Diseases
- Public Health
Background:
- Chronic kidney disease (CKD) is a known risk factor for severe outcomes and mortality in Coronavirus disease 2019 (COVID-19).
- Limited research exists on the post-COVID-19 prognosis for CKD patients, particularly those not requiring renal replacement therapy.
- Understanding these outcomes is crucial for managing CKD patients during and after the pandemic.
Purpose of the Study:
- To investigate the outcomes of CKD patients after surviving COVID-19.
- To compare the post-COVID-19 period in CKD patients with a control group of CKD patients who did not contract COVID-19.
- To assess kidney function, respiratory symptoms, dialysis requirements, and mortality rates.
Main Methods:
- A multicenter observational study included CKD patients (GFR < 60 ml/min/1.73 m²) who survived COVID-19.
- Exclusion criteria included CKD caused by diabetic nephropathy, polycystic kidney disease, and glomerulonephritis.
- A control group of CKD patients with similar characteristics but no COVID-19 infection was used for comparison.
Main Results:
- The COVID-19 group (173 patients) showed significantly higher creatinine levels at 1 month post-infection compared to the control group (207 patients).
- Respiratory symptoms were more prevalent in the COVID-19 group at 1 and 3 months post-diagnosis.
- Mortality at 3 months (5.2% vs. 1.4%) and the need for dialysis (8.1% vs. 3.4%) were significantly higher in the COVID-19 survivors.
Conclusions:
- COVID-19 infection is associated with increased mortality in CKD patients.
- Survivors of COVID-19 with CKD experience significant deterioration in kidney function and an increased need for dialysis post-infection.
- CKD patients who contract COVID-19 are at higher risk for persistent respiratory symptoms.
Purpose:
Coronavirus disease 2019 (COVID-19) has a higher mortality in the presence of chronic kidney disease (CKD). However, there has not been much research in the literature concerning the outcomes of CKD patients in the post-COVID-19 period. We aimed to investigate the outcomes of CKD patients not receiving renal replacement therapy.
Methods:
In this multicenter observational study, we included CKD patients with a GFR < 60 ml/min/1.73 m2 who survived after confirmed COVID-19. Patients with CKD whose kidney disease was due to diabetic nephropathy, polycystic kidney disease and glomerulonephritis were not included in this study. CKD patients with similar characteristics, who did not have COVID-19 were included as the control group.
Results:
There were 173 patients in the COVID-19 group and 207 patients in the control group. Most patients (72.8%) were treated as inpatient in the COVID-19 group (intensive care unit hospitalization: 16.7%, acute kidney injury: 54.8%, needing dialysis: 7.9%). While there was no significant difference between the baseline creatinine values of the COVID-19 group and the control group (1.86 and 1.9, p = 0.978, respectively), on the 1st month, creatinine values were significantly higher in the COVID-19 group (2.09 and 1.8, respectively, p = 0.028). Respiratory system symptoms were more common in COVID-19 patients compared to the control group in the 1st month and 3rd month follow-ups (p < 0.001). Mortality at 3 months after the diagnosis of COVID-19 was significantly higher in the COVID-19 group than in the control group (respectively; 5.2% and 1.4%, p:0.037). Similarly, the rate of patients requiring dialysis for COVID-19 was significantly higher than the control group (respectively; 8.1% and 3.4%, p: 0.045).
Conclusions:
In CKD patients, COVID-19 was associated with increased mortality, as well as more deterioration in kidney function and higher need for dialysis in the post-COVID-19 period. These patients also had higher rate of ongoing respiratory symptoms after COVID-19.
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention

